Characteristics of lung cancer in women: Importance of hormonal and growth factors
Authors:
- Valérie Lauwers-CancesVLValérie Lauwers-Cances
- Camille AlleraCACamille Allera
- Laurent BrouchetLBLaurent Brouchet
- Julie MiliaJMJulie Milia
- Yvan NicaiseYNYvan Nicaise
- Julie LaurentJLJulie Laurent
- Marie-Bernadette DelisleMDMarie-Bernadette Delisle
- Gilles FavreGilles Favre
- Alain DidierADAlain Didier
- Julien MazièresJulien Mazières
- 1 June 2012
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 76 (3) , 280-285
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancerNature Reviews Cancer, 2010
- Estrogen Receptor Signaling in Lung CancerSeminars in Oncology, 2009
- Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR MutationClinical Cancer Research, 2009
- Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancerLung Cancer, 2009
- Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancerLung Cancer, 2006
- Estrogen Receptor α and β are Prognostic Factors in Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Erlotinib in Lung Cancer — Molecular and Clinical Predictors of OutcomeNew England Journal of Medicine, 2005
- Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cellsSteroids, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2004